Although not all patients had sufficient numbers of CD56bright NK cells, as previously shown (67), we found that both NK cell maturation subsets displayed a reduced CD122 expression in AML patients (Figure 7A). This evidence concerns the gene IL2RB and acute myeloid leukemia.